The duration of TCR/pMHC interactions regulates CTL effector function and tumor-killing capacity. (Q39819950)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19637198%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

title

The duration of TCR/pMHC interactions regulates CTL effector function and tumor-killing capacity (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19637198%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

author

Pablo Alberto Gonzalez

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19637198%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

Alexis M Kalergis

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19637198%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

author name string

Erick Riquelme

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19637198%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

Leandro J Carreño

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19637198%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

language of work or name

English

0 references

publication date

1 August 2009

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19637198%20AND%20SRC:MED&resulttype=core&format=json

European Journal of Immunology

3 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19637198%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

volume

39

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19637198%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

issue

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19637198%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

page(s)

2259-2269

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19637198%20AND%20SRC:MED&resulttype=core&format=json

Improving immunotherapy by conditionally enhancing MHC class I presentation of tumor antigen-derived Peptide epitopes

3 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939341

Alloantigen affinity and CD4 help determine severity of graft-versus-host disease mediated by CD8 donor T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939341

Functionally impaired HIV-specific CD8 T cells show high affinity TCR-ligand interactions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939341

TCR signal transduction in antigen-specific memory CD8 T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939341

Naive and innate memory phenotype CD4+ T cells have different requirements for active Itk for their development

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939341

Cutting edge: cytotoxic granule polarization and cytolysis can occur without central supramolecular activation cluster formation in CD8+ effector T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939341

Distinct CD8+ T cell repertoires primed with agonist and native peptides derived from a tumor-associated antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939341

A modified tyrosinase-related protein 2 epitope generates high-affinity tumor-specific T cells but does not mediate therapeutic efficacy in an intradermal tumor model

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939341

Modulation of T cell function by TCR/pMHC binding kinetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939341

7 January 2021

T cell activation and the cytoskeleton

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939341

7 January 2021

Regulation of MAPK signaling pathways through immunophilin-ligand complex

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939341

7 January 2021

The impact of duration versus extent of TCR occupancy on T cell activation: a revision of the kinetic proofreading model

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939341

7 January 2021

Fas and perforin pathways as major mechanisms of T cell-mediated cytotoxicity

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939341

7 January 2021

T cells targeted against a single minor histocompatibility antigen can cure solid tumors

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939341

7 January 2021

CD8 T cell responses to infectious pathogens.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939341

7 January 2021

Regulation of interferon-gamma during innate and adaptive immune responses

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939341

7 January 2021

Efficient T cell activation requires an optimal dwell-time of interaction between the TCR and the pMHC complex

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939341

7 January 2021

T cell receptor binding kinetics required for T cell activation depend on the density of cognate ligand on the antigen-presenting cell.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939341

7 January 2021

Kinetic proofreading in T-cell receptor signal transduction

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939341

7 January 2021

Quantitation of antigen-presenting cell MHC class II/peptide complexes necessary for T-cell stimulation

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939341

7 January 2021

The minimal number of class II MHC-antigen complexes needed for T cell activation

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939341

7 January 2021

Serial triggering of many T-cell receptors by a few peptide-MHC complexes

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939341

7 January 2021

From TCR Engagement to T Cell Activation

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939341

7 January 2021

Sustained signaling leading to T cell activation results from prolonged T cell receptor occupancy. Role of T cell actin cytoskeleton

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939341

7 January 2021

A temporal and spatial summation model for T-cell activation: signal integration and antigen decoding

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939341

7 January 2021

Activated TCRs remain marked for internalization after dissociation from pMHC

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939341

7 January 2021

The half-life of the T-cell receptor/peptide-major histocompatibility complex interaction can modulate T-cell activation in response to bacterial challenge.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939341

7 January 2021

Characterization of the ovalbumin-specific TCR transgenic line OT-I: MHC elements for positive and negative selection

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939341

7 January 2021

T-cell receptor binding affinities and kinetics: impact on T-cell activity and specificity

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939341

7 January 2021

Lineage relationship and protective immunity of memory CD8 T cell subsets

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939341

7 January 2021

T-cell memory: new perspectives

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939341

7 January 2021

Acquisition of full effector function in vitro paradoxically impairs the in vivo antitumor efficacy of adoptively transferred CD8+ T cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939341

7 January 2021

Qualitative and quantitative differences in T cell receptor binding of agonist and antagonist ligands.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939341

7 January 2021

Flow cytometric detection of degranulation reveals phenotypic heterogeneity of degranulating CMV-specific CD8+ T lymphocytes in rhesus macaques

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939341

7 January 2021

Sensitive and viable identification of antigen-specific CD8+ T cells by a flow cytometric assay for degranulation

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939341

7 January 2021

Ex vivo identification, isolation and analysis of tumor-cytolytic T cells.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939341

7 January 2021

Lytic versus stimulatory synapse in cytotoxic T lymphocyte/target cell interaction: manifestation of a dual activation threshold

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939341

7 January 2021

Effects of epitope modification on T cell receptor-ligand binding and antigen recognition by seven H-2Kd-restricted cytotoxic T lymphocyte clones specific for a photoreactive peptide derivative

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939341

7 January 2021

Discrepancy between ELISPOT IFN-gamma secretion and binding of A2/peptide multimers to TCR reveals interclonal dissociation of CTL effector function from TCR-peptide/MHC complexes half-life

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939341

7 January 2021

Low TCR avidity and lack of tumor cell recognition in CD8+ T cells primed with the CEA-analogue CAP1-6D peptide

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939341

7 January 2021

Suboptimal activation of melanoma infiltrating lymphocytes (TIL) due to low avidity of TCR/MHC-tumor peptide interactions

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939341

7 January 2021

Mobilizing the low-avidity T cell repertoire to kill tumors

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939341

7 January 2021

Optimization of a self antigen for presentation of multiple epitopes in cancer immunity

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939341

7 January 2021

Expression of HLA class I-specific inhibitory natural killer cell receptors in HIV-specific cytolytic T lymphocytes: impairment of specific cytolytic functions

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939341

7 January 2021

In vivo expression of natural killer cell inhibitory receptors by human melanoma-specific cytolytic T lymphocytes

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939341

7 January 2021

Up-regulation of Inhibitory Natural Killer Receptors CD94/NKG2A with Suppressed Intracellular Perforin Expression of Tumor-Infiltrating CD8+T Lymphocytes in Human Cervical Carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939341

7 January 2021

Upregulation of PD-1 Expression on Circulating and Intrahepatic Hepatitis C Virus-Specific CD8+ T Cells Associated with Reversible Immune Dysfunction

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939341

7 January 2021

T-cell receptor binding kinetics in T-cell development and activation

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939341

7 January 2021

Immune complex-induced enhancement of bacterial antigen presentation requires Fcgamma receptor III expression on dendritic cells.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939341

7 January 2021

Andrographolide interferes with T cell activation and reduces experimental autoimmune encephalomyelitis in the mouse

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939341

7 January 2021